InvestorsHub Logo
Post# of 251888
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: oc631 post# 168107

Monday, 10/14/2013 4:49:53 PM

Monday, October 14, 2013 4:49:53 PM

Post# of 251888

The only obstacle to reaching 90%+ SVR rates in all genotypes is GILD's in-house ambitions.

I think their in-house strategy will prove right and GS-5816 GT3 data (including the phase II combo with sofo) will reach the 90%+ SVR rates and move to phase III next year.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.